 |
 |

Effect of Food Additives on Hyperphosphatemia Among Patients With End-stage Renal DiseaseA Randomized Controlled Trial
Catherine Sullivan, MS, RD, LD;
Srilekha S. Sayre, MS, RD, LD;
Janeen B. Leon, MS, RD, LD;
Rhoderick Machekano, MPH, PhD;
Thomas E. Love, PhD;
David Porter, BA;
Marquisha Marbury, AAS;
Ashwini R. Sehgal, MD
JAMA. 2009;301(6):629-635.
Context High dietary phosphorus intake has deleterious consequences for renal patients and is possibly harmful for the general public as well. To prevent hyperphosphatemia, patients with end-stage renal disease limit their intake of foods that are naturally high in phosphorus. However, phosphorus-containing additives are increasingly being added to processed and fast foods. The effect of such additives on serum phosphorus levels is unclear.
Objective To determine the effect of limiting the intake of phosphorus-containing food additives on serum phosphorus levels among patients with end-stage renal disease.
Design, Setting, and Participants Cluster randomized controlled trial at 14 long-term hemodialysis facilities in northeast Ohio. Two hundred seventy-nine patients with elevated baseline serum phosphorus levels (>5.5 mg/dL) were recruited between May and October 2007. Two shifts at each of 12 large facilities and 1 shift at each of 2 small facilities were randomly assigned to an intervention or control group.
Intervention Intervention participants (n=145) received education on avoiding foods with phosphorus additives when purchasing groceries or visiting fast food restaurants. Control participants (n=134) continued to receive usual care.
Main Outcome Measure Change in serum phosphorus level after 3 months.
Results At baseline, there was no significant difference in serum phosphorus levels between the 2 groups. After 3 months, the decline in serum phosphorus levels was 0.6 mg/dL larger among intervention vs control participants (95% confidence interval, –1.0 to –0.1 mg/dL). Intervention participants also had statistically significant increases in reading ingredient lists (P<.001) and nutrition facts labels (P = .04) but no significant increase in food knowledge scores (P = .13).
Conclusion Educating end-stage renal disease patients to avoid phosphorus-containing food additives resulted in modest improvements in hyperphosphatemia.
Trial Registration clinicaltrials.gov Identifier: NCT00583570
Author Affiliations: Division of Nephrology (Mss Sullivan, Sayre, Leon, and Marbury, Mr Porter, and Dr Sehgal) and Center for Health Care Research and Policy (Drs Machekano, Love, and Sehgal), MetroHealth Medical Center, and Center for Reducing Health Disparities (Mss Sullivan, Sayre, Leon, and Marbury, Mr Porter, and Dr Sehgal), and Departments of Medicine (Mss Sullivan, Sayre, Leon, and Marbury, Mr Porter, and Drs Machekano, Love, and Sehgal), Epidemiology and Biostatistics (Dr Sehgal), and Bioethics (Dr Sehgal), Case Western Reserve University, Cleveland, Ohio.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED LETTERS
Reducing Serum Phosphorus Concentration in Patients With End-Stage Renal Disease
Antonio Alberto Lopes and Gildete Barreto Lopes
JAMA. 2009;301(23):2443-2444.
EXTRACT
| FULL TEXT
Reducing Serum Phosphorus Concentration in Patients With End-Stage Renal Disease—Reply
Ashwini R. Sehgal, Catherine Sullivan, and Srilekha S. Sayre
JAMA. 2009;301(23):2444.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Kidney Failure
Lise M. Stevens, Cassio Lynm, and Richard M. Glass
JAMA. 2009;301(6):686.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Phosphorus Additives in Food and their Effect in Dialysis Patients
Uribarri
CJASN 2009;4:1290-1292.
FULL TEXT
Phosphorus and Potassium Content of Enhanced Meat and Poultry Products: Implications for Patients Who Receive Dialysis
Sherman and Mehta
CJASN 2009;4:1370-1373.
ABSTRACT
| FULL TEXT
Why Is the Mortality of Dialysis Patients in the United States Much Higher than the Rest of the World?
Foley and Hakim
J. Am. Soc. Nephrol. 2009;20:1432-1435.
FULL TEXT
Reducing Serum Phosphorus Concentration in Patients With End-Stage Renal Disease
Lopes and Lopes
JAMA 2009;301:2443-2444.
FULL TEXT
|